Filing Details
Zura Bio Ltd (NASDAQ:ZURA) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:ZURA
Zura Bio Ltd (ZURA) Files Quarterly Report for Q0
Zura Bio Ltd (NASDAQ:ZURA) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
At publication ·
What changed
Zura Bio Ltd (NASDAQ:ZURA) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Zura Bio Ltd filed its quarterly report (Form 10-Q) with the SEC on August 11, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $5.56 with a market capitalization of $263.3 million as of the filing date.
- The article does not disclose Q0 revenue figures, limiting visibility into the company's financial performance for the period.
Market Context
Zura Bio Ltd's stock currently trades at $5.56 with a market capitalization of $263.3M.
The 10-Q provides Zura Bio Ltd's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Zura Bio Ltd are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ZURA Stock Page
Frequently Asked Questions
Where can I read ZURA's SEC filings?
Browse all filings on our ZURA SEC filings page.
What types of SEC filings does Zura Bio Ltd file?
Public companies like Zura Bio Ltd file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.